Cargando…
Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
BACKGROUND: Autotaxin (ATX) is a secreted enzyme that converts lysophosphatidylcholine to lysophosphatidic acid (LPA). LPA stimulates cell proliferation and migration and promotes wound repair following tissue damage. ATX levels are directly correlated with stage and grade in several human cancers....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408149/ https://www.ncbi.nlm.nih.gov/pubmed/37550785 http://dx.doi.org/10.1186/s13046-023-02780-4 |